DXR · Daxor Corp
United States · RS rating 33 · As of 2026-10-14
| Price | 10.09 USD |
|---|---|
| 1-day change | -2.5% |
| RS rating (overall / 1M / 3M / 12M) | 33 / 24 / 47 / 25 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 20 / 7 / 20 |
| Industry group (rank) | Medical-Systems/Equip (93) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +31.6% |
| Market cap (USD) | $56.9M |